140 related articles for article (PubMed ID: 31918175)
1. Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study?
Stordeur S; Schillemans V; Savoye I; Vanschoenbeek K; Leroy R; Macq G; Verleye L; De Gendt C; Nuyts S; Vermorken J; Beguin C; Grégoire V; Van Eycken L
Oral Oncol; 2020 Mar; 102():104561. PubMed ID: 31918175
[TBL] [Abstract][Full Text] [Related]
2. Influence of comorbidity on therapeutic decision making and impact on outcomes in patients with head and neck squamous cell cancers: Results from a prospective cohort study.
Agarwal J; Adulkar D; Swain M; Chakraborty S; Gupta T; Budrukkar A; Ghosh-Laskar S; Murthy V
Head Neck; 2019 Mar; 41(3):765-773. PubMed ID: 30552822
[TBL] [Abstract][Full Text] [Related]
3. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
[TBL] [Abstract][Full Text] [Related]
6. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
7. Impact of age, comorbidity, and WHO performance status on delay of treatment in patients undergoing fast-track work-up for head and neck cancer.
Carlsen AH; Eriksen JG; Godballe C; Johansen J; Sørensen JA; Bjørndal K
J Geriatr Oncol; 2019 Mar; 10(2):259-264. PubMed ID: 29950282
[TBL] [Abstract][Full Text] [Related]
8. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.
Datema FR; Ferrier MB; van der Schroeff MP; Baatenburg de Jong RJ
Head Neck; 2010 Jun; 32(6):728-36. PubMed ID: 19827120
[TBL] [Abstract][Full Text] [Related]
9. Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.
Chen JH; Yen YC; Yang HC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Wu SY
Medicine (Baltimore); 2016 Apr; 95(14):e3268. PubMed ID: 27057882
[TBL] [Abstract][Full Text] [Related]
10. All-Cause 30-Day Mortality After Surgical Treatment for Head and Neck Squamous Cell Carcinoma in the United States.
Bukatko AR; Patel PB; Kakarla V; Simpson MC; Adjei Boakye E; Patel SH; Stamatakis KA; Varvares MA; Osazuwa-Peters N
Am J Clin Oncol; 2019 Jul; 42(7):596-601. PubMed ID: 31166207
[TBL] [Abstract][Full Text] [Related]
11. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival.
Reyes-Gibby CC; Anderson KO; Merriman KW; Todd KH; Shete SS; Hanna EY
J Pain; 2014 Oct; 15(10):1015-22. PubMed ID: 25043982
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma.
Wang JR; Habbous S; Espin-Garcia O; Chen D; Huang SH; Simpson C; Xu W; Liu FF; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Goldstein DP; Liu G
Head Neck; 2016 May; 38(5):736-42. PubMed ID: 25521753
[TBL] [Abstract][Full Text] [Related]
13. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different comorbidity measures for oral cancer patients with surgical intervention: A longitudinal study from a single cancer center.
Lee CC; Ho HC; Su YC; Chen PC; Yu CH; Yang CC
Auris Nasus Larynx; 2016 Jun; 43(3):322-9. PubMed ID: 26642942
[TBL] [Abstract][Full Text] [Related]
15. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
16. Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany.
Göllnitz I; Inhestern J; Wendt TG; Buentzel J; Esser D; Böger D; Mueller AH; Piesold JU; Schultze-Mosgau S; Eigendorff E; Schlattmann P; Guntinas-Lichius O
Cancer Med; 2016 Nov; 5(11):3260-3271. PubMed ID: 27726294
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
[TBL] [Abstract][Full Text] [Related]
18. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
[TBL] [Abstract][Full Text] [Related]
19. Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer.
Huo M; Panizza B; Bernard A; Porceddu SV
Oral Oncol; 2018 Feb; 77():43-48. PubMed ID: 29362125
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Comorbidity on Survival in Patients With Head and Neck Squamous Cell Carcinoma: A Nationwide Case-Control Study Spanning 35 Years.
Ruud Kjær EK; Jensen JS; Jakobsen KK; Lelkaitis G; Wessel I; von Buchwald C; Grønhøj C
Front Oncol; 2020; 10():617184. PubMed ID: 33680938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
